Base molecular dos fatores de virulência de Streptococcus equi

Autores

  • Tania Alexandra Ortega Sierra Universidade Federal Rural de Pernambuco (UFRPE), Recife, PE.
  • Atzel Candido Acosta Abad Universidade Federal Rural de Pernambuco (UFRPE), Recife, PE.
  • José Wilton Pinheiro Junior Universidade Federal Rural de Pernambuco (UFRPE), Recife, PE.

DOI:

https://doi.org/10.26605/medvet-v12n3-2394

Palavras-chave:

adenite equina, genes, fatores de virulência, vacinas.

Resumo

Streptococcus equi subespécie equi (S. equi) é responsável pela adenite equina, doença infecto-contagiosa que ocorre com elevadas prevalências em todo o mundo. Desde a primeira descrição desta enfermidade não tem sido possível realizar o controle da mesma, o que pode ser explicado pela variabilidade nos genes de virulência. Ao longo dos anos alguns estudos foram realizados para identificar os fatores de virulência envolvidos na patogenia da enfermidade, no entanto, ainda existem algumas lacunas sobre a ocorrência e mecanismos desses genes na patogenia da doença. Desta forma, objetiva-se com esta revisão discorrer sobre os principais fatores de virulência de S. equi subespécie equi, os genes que participam na expressão dos mesmos e avanços no desenvolvimento de vacinas.

Downloads

Não há dados estatísticos.

Referências

Anzai, T.; Timoney, J.; Kuwamoto, Y.; Fujita, Y.; Wada, R.; Inoue, T. In vivo pathogenicity and resistance to phagocytosis of Streptococcus equi strains with different levels of capsule expression. Veterinary Microbiology, 67: 277-286, 1999.

Armstrong, D.; Johns, M. Culture conditions affect the molecular weight properties of hyaluronic acid produced by Streptococcus zooepidemicus. Applied and Environmental Microbiology, 63(7), 2759–2764, 1997. Artiushin, S.; Timoney, J.; Sheoran, A.; Muthupalani, S. Characterization and immunogenicity of pyrogenic mitogens SePEH and SePE-I of Streptococcus equi. Microbial Pathogenesis, 32: 71–85, 2002.

Babu, M.; Priya, M.; Selvan, A.; Madera, M.; Gough, J.; Aravind, L.; Sankaran, K. A Database of Bacterial Lipoproteins (DOLOP) with Functional assignments to predicted lipoproteins. Journal of Bacteriology, 188(8): 2761–2773, 2006.

Baker, J.; Dong, S.; Pritchard, D. The hyaluronan lyase of Streptococcus pyogenes bacteriophage H4489A. Biochemical Journal, 365: 317-322, 2002.

Bessen, D.; Kalia, A. Genomic localization of a t serotype locus to a recombinatorial zone encoding extracellular matrix-binding proteins in Streptococcus pyogenes. Infection and Immunity, 70(3); 1159–1167, 2002. Blank, L.; Hugenholtz, P.; Nielsen, L. Evolution of the hyaluronic acid synthesis (has) operon in Streptococcus zooepidemicus and other pathogenic Streptococci. Journal of Molecular Evolution, doi:10.1007/s00239-008-9117-1, 2008.

Borst, L.; Patterson, S.; Lanka, S.; Barger, A.; Fredrickson, R.; Maddox, C. Evaluation of a commercially available modified live Streptococcus equi subsp equi vaccine in ponies. American Journal of Veterinary Research, 72(8): 1130-1138, 2011.

Boschwitz, J.; Timoney, J. Inhibition of C3 Deposition on Streptococcus equi subsp. equi by M Protein: a Mechanism for Survival in Equine Blood. Infection and Immunity, 62(8): 3515-3520, 1994.

Boyle, A.; Timoney, J.; Newton, J.; Hines, M.; Waller, A.; Buchanan, B. Streptococcus equi infections in horses: guidelines for treatment, control, and prevention of strangles-revised consensus statement. Journal of Veterinary Internal Medicine, 32; 633-647, 2018.

Commons, R.; Smeesters, P.; Proft, T.; Fraser, J.; Robins-Browne, R.; Curtis, N. Streptococcal superantigens: categorization and clinical associations. Trends in Molecular Medicine, 20(1): 48-62, 2014.

Cursons, R.; Patty, O.; Steward, K.; Waller, A. Strangles in horses can be caused by vaccination with Pinnacle I. N. Vaccine, 33: 3440–3443, 2015. Flanagan, J.; Collin, N.; Timoney, J.; Mitchell, T.; Mumford, J.; Chanter, N. Characterization of the haemolytic activity of Streptococcus equi. Microbial Pathogenesis, 24: 211–221, 1998.

Flock, M.; Jacobsson, K.; Frykberg, L.; Hirst, T.; Franklin, A.; Guss, B.; Flock, J. Recombinant Streptococcus equi proteins protect mice in challenge experiments and induce immune response in horses. Infection and Immunity, 72(6): 3228–3236, 2004.

Flock, M.; Karlström, A.; Lannergård, J.; Guss, B.; Flock, J.I. Protective effect of vaccination with recombinant proteins from Streptococcus equi subspecies equi in a strangles model in the mouse. Vaccine, 24: 4144–4151, 2006.

Hamilton, A.; Robinson, C.; Sutcliffe, I.; Slater, J.; Maskell, D.; Davis-Poynter, N.; Smith, K.; Waller, A.; Harrington, D. mutation of the maturase lipoprotein attenuates the virulence of Streptococcus equi to a greater extent than does loss of general lipoprotein lipidation. Infection and Immunity, 74(12): 6907-6919, 2006.

Harrington, D.; Greated, J.; Chanter, N.; Sutcliffe, I. Identification of lipoprotein homologues of Pneumococcal PsaA in the equine pathogens Streptococcus equi and Streptococcuszooepidemicus. Infection and Immunity, 68(10): 6048–6051, 2000.

Harrington, D.; Sutcliffe, I.; Chanter, N. The molecular basis of Streptococcus equi infection and disease. Microbes and Infection, 4: 501– 510, 2002.

Holden, M.; Heather, Z.; Paillot, R.; Steward, K.; Webb, K.; Ainslie, F.; Jourdan, T.; Bason, N.; Holroyd, N.; Mungall, K.; Quail, M.; Sanders, M.; Simmonds, M.; Willey, D.; Brooks, K.; Aanensen, D.; Spratt, B.; Jolley, K.; Maiden, M.; Kehoe, M.; Chanter, N.; Bentley, S.; Robinson, C.; Maskell, D.; Parkhill, J.; Waller, A. Genomic evidence for the evolution of Streptococcus equi: host restriction, increased virulence, and genetic exchange with human pathogens. PLoS Pathogens, 5(3): e1000346, 2009.

Humar, D.; Datta, V.; Bast, D.; Beall, B.; De Azavedo, J.; Nizet, V. Streptolysin S and necrotising infections produced by group G streptococcus. The Lancet, 359: 124–129, 2002.

Hynes, W.; Walton, S. Hyaluronidases of Grampositive bacteria. FEMS Microbiology Letters, 183: 201-207, 2000.

Janulczyk, R.; Pallon, J.; Björk, L. Identification and characterization of a Streptococcus pyogenes ABC transporter with multiple specificity for metal cations. Molecular Microbiology, 34(3): 596-606, 1999.

Javed, R.; Taku, A.; Gangil, R.; Sharma, R. Molecular characterization of virulence genes of Streptococcus equi subsp. equi and Streptococcus equi subsp. zooepidemicus in equines. Veterinary World, 9(8): 875-881, 2016. Libardoni, F.; Machado, G.; Gressler, L.T.; Kowalski, A.P.; Diehl, G.N.; Carboneiro dos Santos, L.; Corbellini, L.G.; Castagna de Vargas, A. Prevalence of Streptococcus equi subsp. equi in horses and associated risk factors in the State of Rio Grande do Sul, Brazil. Research in Veterinary Science, 104: 53-57, 2016.

Lidén, Å.; Karlström, Å.; Lannergård, J.; Kalamajski, S.; Guss, B.; Rubin, K.; Rydén, C. A fibronectin-binding protein from Streptococcus equi binds collagen and modulates cell-mediated collagen gel contraction. Biochemical and Biophysical Research Communications, 340: 604–610, 2006.

Lindmark, H.; Guss, B. SFS, a Novel fibronectinbinding protein from streptococcus equi, inhibits the binding between fibronectin and collagen. Infection and Immunity, 67(5), 2383–2388, 1999.

Lindmark, H.; Nilsson, M.; Guss, B. Comparison of the Fibronectin-Binding Protein FNE from Streptococcus equi subspecies equi with FNZ from S. equi subspecies zooepidemicus reveals a major and conserved difference. Infection and Immunity, 69(5): 3159–3163, 2001.

Lindsay, A.M.; Zhang, M.; Mitchell, Z.; Holden, M.; Waller, A.; Sutcliffe, I.; Black, G. The Streptococcus equi prophage-encoded protein SEQ2045 is a hyaluronan-specific hyaluronate lyase that is produced during equine infection. Microbiology, 155: 443–449, 2008.

Ma, W.; Ma, H.; Fogerty, F.; Mosher, D. Bivalent ligation of the collagen-binding modules of fibronectin by SFS, a non-anchored bacterial protein of Streptococcus equi. The Journal of Biological Chemestry, 290(8): 4866–4876, 2015.

Malke, H.; Steiner, K.; Gase, K.; Frank, C. Expression and regulation of the streptokinase gene. Methods, 21: 111-124, 2000.

Mallicote, M. Update on Streptococcus equi subsp equi infections. Veterinary Clinics of North America: Equine Practice. 31: 27-41, 2015.

Meehan, M.; Lynagh, Y.; Woods, C.; Owen, P. The fibrinogen-binding protein (FgBP) of Streptococcus equi subsp. equi additionally binds IgG and contributes to virulence in a mouse model. Microbiology, 147: 3311–3322, 2001.

Meehan, M.; Muldowney, D.; Watkins, N.; Owen, P. Localization and characterization of the ligand-binding domain of the fibrinogenbinding protein (FgBP) of Streptococcus equi subsp. equi. Microbiology, 146: 1187–1194, 2000.

Meehan, M.; Nowlan, P.; Owen, P. Affinity purification and characterization of a fibrinogen-binding protein complex which protects mice against lethal challenge with Streptococcus equi subsp. equi. Microbiology, 144: 993-1003, 1998.

Moraes, C. M.; Vargas, A. P.; Leite, F. P.; Nogueira, C. E.; Turnes, C. G. Adenite equina: sua etiologia, diagnóstico e controle. Ciência Rural, Santa Maria, 39(6): 1944-1952, 2009.

Nakayama, H.; Kurokawa, K.; Lee, B. Lipoproteins in bacteria: structures andbiosynthetic pathways. The FEBS Journal, 4247–4268, 2012.

Paillot, R.; Wright, N.; McLean, R.; Darby, A.; Anderson, E.; Steward, K.; Webb, K.; Priestnall, S.; Erles, K.; Smith, K.; Efstratiou, A.; Holden, M.; Robinson, C.; Waller, A. Diversity of superantigens in Streptococcus equi and zooepidemicus populations. Journal of Equine Veterinary Science, 32: S24-S25, 2012.

Robinson, C.; Frykberg, L.; Flock, M.; Guss, B.; Waller, A.; Flock, J.I. Strangvac: A recombinant fusion protein vaccine that protects against strangles, caused by Streptococcus equi. Vaccine, 36: 1484–1490, 2018. Robinson, C.; Heather, Z.; Slater, J.; Potts, N.; Steward, K.; Maskell, D.; Fontaine, M.; Lee, J.; Smith, K.; Waller, A. Vaccination with a live multi-gene deletion strain protects horses against virulent challenge with Streptococcus equi. Vaccine, 33: 1160–1167, 2015.

Slater, J. Bacterial Infections of the Equine Respiratory Tract. In: B. McGorum, P.D.; E. Robinson, E.; Schumacher, J. Equine Respiratory Medicine and Surgery. Philadelphia: Elsevier, 2007. p.314-324.

Smith, N.; Taylor, E.; Lindsay, A.M.; Charnock, S.; Turkenburg, J.; Dodson, E.; Davies, G.; Black, G. Structure of a group A streptococcal phage-encoded virulence factor reveals a catalytically active triple-stranded b-helix. Proceedings of the National Academy of Sciences, 102(49): 17652–17657, 2005.

Stanchi, N.O.; Martino, P.; Gentilini, E.; Reinoso, E.; Echeverría, M.; Leardini, N.; Copes, J. Microbiología veterinaria. Buenos Aires: Inter-médica, 2007.

Tewodros, W.; Karlsson, I.; Kronvall, G. Allelic variation of the streptokinase gene in Bhemolytic streptococci group C and G isolates of human origin. FEMS Immunology and Medical Microbiology, 13: 29-34, 1996. Timoney, J. The pathogenic equine streptococci. Veterinary Research, a Journal on Animal Infection, 35(4): 397-409, 2004.

Timoney, J.; Mukhtar, M. The protective M proteins of the equine group C streptococci. Veterinary Microbiology, 3(4): 389-395, 1993.

Timoney, J.; Kumar, P.; Muthupalani, S. Interaction of Streptococcus equi with the equine nasopharynx. International Congress Series, 1289: 267-270, 2006.

Timoney, J.; Qin, A.; Muthupalani, S.; Artiushin, S. Vaccine potential of novel surface exposed and secreted proteins of Streptococcus equi. Vaccine, 25: 5583–5590, 2007.

Tiouajni, M.; Durand, D.; Blondeau, K.; Graille, M.; Urvoas, A.; Valerio-Lepiniec, M.; Guellouz, A.; Aumont-Nicaise, M.; Minard, P.; Tilbeurgh, H. Structural and functional analysis of the fibronectin-binding protein FNE from Streptococcus equi spp. equi. The FEBS Journal, 281: 5513–5531, 2014.

Velineni, S.; Sheoran, A.; Breathnach, C.; Rash, N.; Paillot, R.; Timoney, J. Mitogenic Equine Isolates of Streptococcus zooepidemicus From North America Host Superantigen Genes Similar to Those Hosted in Europe. Journal of Equine Veterinary Science, 49: 40-44, 2017.

Waller, A. Strangles: Taking steps towards eradication. Veterinary Microbiology, 167: 50–60, 2013.

Waller, A.S.; Sellon, D.C.; Sweeney, C.R.; Timoney, P.J.; Newton, R.; Hines, M.T. Streptococcal Infections. In Sellon, D.; Long, M. Equine Infectious Diseases. United States: Elsevier, 2014.p.265-277.

Waller, A.; Paillot, R; Timoney, J. Streptococcus equi: a pathogen restricted to one host. Journal of Medical Microbiology, 60: 1231–1240, 2011. Wibawan, W.; Pasaribu, F.; Utama, I.; Abdulmawjood, A.; Lämmler, C. The role of hyaluronic acid capsular material of Streptococcus equi subsp. zooepidemicus in mediating adherence to HeLa cells and in resisting phagocytosis. Research in Veterinary Science, doi:10.1053/rvsc.1998.0287, 1999.

Zakeri, A.; Rasaee, M.; Pourzardosht, N. Enhanced hyluronic acid production in Streptococcus zooepidemicus by over expressing HasA and molecular weight control with Niscin and glucose. Biotechnology Reports, doi:https://doi.org/10.1016/j.btre.2017.02.007, 2017.

Downloads

Publicado

20-03-2019

Como Citar

Ortega Sierra, T. A., Acosta Abad, A. C., & Pinheiro Junior, J. W. (2019). Base molecular dos fatores de virulência de Streptococcus equi. Medicina Veterinária, 12(3), 186–192. https://doi.org/10.26605/medvet-v12n3-2394

Edição

v. 12 n. 3 (2018)

Seção

Medicina Veterinária Preventiva

Licença

  • A Revista de Medicina Veterinária permite que o autor retenha os direitos de publicação sem restrições, utilizando para tal a licença  Creative Commons CC BY-NC-SA 4.0.
  • De acordo com os termos seguintes:
  • Atribuição — Você deve dar o crédito apropriado, prover um link para a licença e indicar se mudanças foram feitas. Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso.
  • NãoComercial — Você não pode usar o material para fins comerciais.
  • CompartilhaIgual — Se você remixar, transformar, ou criar a partir do material, tem de distribuir as suas contribuições sob a mesma licença que o original.
  • Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.